Related Experiment Video
Updated: Sep 28, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
[Relationship between HLA-DRB1 alleles and idopathic thrombocytopenic purpura in children]
Hongmei Wang1, Baijun Shen, Wenying Yan
1Department of Paediatrics, Shandong Provincial Hospital, Jinan 250021, China.
Insights
Certain HLA-DRB1 alleles influence susceptibility and treatment response in childhood idiopathic thrombocytopenic purpura (ITP). HLA-DRB1*17 may increase ITP risk, while HLA-DRB1*11 is linked to poor treatment outcomes.
Area of Science:
- Immunogenetics
- Pediatric Hematology
- Molecular Biology
Context:
- Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder affecting platelet counts in children.
- The role of human leukocyte antigen (HLA) genes, specifically HLA-DRB1 alleles, in the pathogenesis and clinical course of childhood ITP is not fully understood.
Purpose:
- To investigate the association between specific HLA-DRB1 alleles and the susceptibility to, and clinical characteristics of, childhood ITP.
- To explore the relationship between HLA-DRB1 alleles and response to standard therapies (steroids and intravenous immunoglobulin).
Summary:
- A study of 42 children with ITP revealed significant associations between certain HLA-DRB1 alleles and the condition.
- HLA-DRB1*17 was found to be associated with increased susceptibility to ITP, while HLA-DRB1*1202 showed a protective effect.
- HLA-DRB1*11 was linked to poor response to steroid and IgG therapy, particularly in adolescent females, and HLA-DRB1*02 was associated with autoantibody positivity (anti-GPIIb/IIIa and anti-GPIb/IX).
Impact:
- These findings suggest that specific HLA-DRB1 alleles are important genetic factors influencing susceptibility and treatment outcomes in childhood ITP.
- This research provides a foundation for further investigation into the precise mechanisms by which genetic factors modulate the clinical course of ITP.
Objective:
To study the relationship between HLA-DRB1 alleles and idiopathic thrombocytopenic purpura (ITP) in children.
Methods:
PCR-SSO was used to identify DRB1 alleles of 42 children with ITP. Among them, anti-GPIIb/IIIa and anti-GPIb/IX autoantibody were detected in 36 cases by modified monoclonal antibody specific immobilization of platelet antigens (MAIPA).
Results:
(1) Compared with healthy controls, HLA-DRB1 * 17 was significantly increased (relative risk = 2.76, P < 0.05, etiologic factor = 0.106 4) and HLA-DRB1 * 1202 decreased (relative risk = 0.20, P < 0.025, prophylactic factor = 0.761 6) in children with ITP. (2) In comparison with patients with good response to steroids and IgG therapy, HLA-DRB1 * 11 was significantly increased (P < 0.025) in patients with a poor response, furthermore, most (5/6) of HLA-DRB1 * 11-positive patients were female teen-ager. (3) Twenty-seven patients (75%) had anti-GPIIb/IIIa and seventeen (47.22%) had anti-GPIb/IX autoantibodies, the positivity rates of both anti-GPIIb/IIIa (P = 0.02) and anti-GPIb/IX (P = 0.01) were associated with HLA-DRB1 * 02. However, the pos./itivity rates of autoantibodies between refractory and non-refractory patients showed no significant difference.
Conclusion:
(1) The DRB1 * 17 seems to predict susceptibility to ITP in children, while DRB1 * 1202 appears to be protective to against ITP. (2) The DRB1 * 11 plays an important role in resistance to steroid and IgG therapy in children with ITP. (3) It seems that the response to the antigenic epitope of GPIIb/IIIa and GPIb/IX is restricted by DRB1 * 02, while the presence of the autoantibodies couldn't predict prognosis. Our preliminary findings indicate that genetic factors influence the clinical course of ITP, but its exact mechanism needs to be further investigated.
Related Concept Videos
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Rh Blood Group
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Type I Diabetes I: Introduction
